Your email has been successfully added to our mailing list.

×
0.00152639048817718 0.00152639048817718 0.000187451463460393 0.00152639048817718 0.00393648073266742 0.00688214658704444 0.00688214658704444 0.0149157807353453
Stock impact report

Gene Therapy Prospects Make Axovant Sciences A Compelling Buy For 2018 [Seeking Alpha]

Axon Enterprise, Inc. (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Summary Axovant Sciences' ( AXON ) licensing deal with Oxford BioMedica ( OTCPK:OXBDF ) is nothing short of a masterstroke. This deal has opened up the gene therapy segment for Axovant Sciences and has positioned the company to make a solid entry in the neurodegenerative disease segment. This transformation from being a small molecule player to a very potent lentiviral vector gene therapy company initially targeting Parkinson's disease or PD has been well received by the investor community. The stock has jumped by a whopping 284% since start of June 2018. But all is not lost yet. Even now, I strongly believe that all those who have missed on the initial rally should be picking up Axovant Sciences since there are solid science and robust commercial fundamentals backing this deal. In this article, I will explain why I consider Axovant Sciences to be a promising investment opportunity for 2018. Parkinson's Disease Is An Area With High Unmet Demand This lic Show less Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AXON alerts
Opt-in for
AXON alerts

from News Quantified
Opt-in for
AXON alerts

from News Quantified